Cervical cancer is the fourth most common malignancy in women of reproductive age
globally. The burden of this disease is highest in low-income and middle-income countries …

Background We sought to summarize human papillomavirus (HPV) vaccine
efficacy/effectiveness (VE) against anal HPV infection and anal intraepithelial neoplasia …

Summary Background In 2020, the World Health Organization (WHO) launched its initiative
to eliminate cervical cancer as a public health problem. To inform global efforts for countries …

Background: The most important causative agent of neoplasms in the anogenital area is the
human papillomavirus (HPV). Due to the anatomical proximity of the genital and anus area …

The burden of cervical cancer is disproportionately distributed globally, with the vast majority
of cases occurring in low-and middle-income countries. Women with human …

After 40 years of its appearance, human immunodeficiency virus (HIV) infection remains a
leading public health challenge worldwide. Since the introduction of antiretroviral treatment …

Key Clinical Points Human Papillomavirus Vaccination Human papillomavirus (HPV) is a
common sexually transmitted virus. Most HPV infections clear or become undetectable …

Background: Human papillomavirus (HPV) vaccination programs are a key intervention in
protecting individuals against HPV-related disease. HIV1-infected individuals are at …

To understand the HPV infection profiles among Chinese HIV/AIDS patients and the HPV
vaccine acceptance among unvaccinated Chinese people with different HIV infection …

Women's HIV incidence rates currently surpass that of men worldwide. 1, 2 Among the
approximately 1.2 million people living with HIV in the United States, 23% are cisgender …